NCT02956044View on ClinicalTrials.gov

Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Type2 Diabetes Mellitus
Interventions
DRUG

Bexagliflozin

Bexagliflozin tablets, 20 mg

DRUG

Metformin

1000 mg metformin

DRUG

Glimepiride

4 mg glimepiride

DRUG

Sitagliptin

100 mg sitagliptin

Trial Locations (1)

47710

Clinical Research Site, Evansville

Sponsors

Lead Sponsor

Theracos
All Listed Sponsors
lead

Theracos

INDUSTRY

NCT02956044 - Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin | Biotech Hunter | Biotech Hunter